Vinay Prasad is out at the FDAÂ after less than three months. It may be the shortest tenure as CBER Director in FDA history. This is an ominous sign for the agency, but probably not just for the reasons you might first think. Vinay Prasad’s departure and gaps in FDA leadership Prasad had three key roles. […]
The post Why sudden Vinay Prasad departure from FDA is about more than Sarepta missteps appeared first on The Niche.